Nikkei 225 climbed 2.07%, KOSPI rose 0.44%, ASX 200 added 0.62%, Hang Seng Index gained 0.48%, Shanghai Composite was 0.43% higher while the Shenzhen Component edged down 0.03%
Asia Pacific stocks were mostly up on Tuesday morning, recovering from the previous session’s battering. Although China’s push to help troubled developers boosted investors sentiment, surging cases of the omicron variant of the coronavirus globally kept moves small overall.
Japan’s Nikkei 225 climbed 2.07% by 3:21 AM GMT and South Korea’s KOSPI rose 0.44%.
In Australia, the ASX 200 added 0.62%. The Reserve Bank of Australia (RBA) released the minutes from its latest meeting earlier in the day, where it said that beginning asset tapering at its first meeting of 2022 and ending it in May is consistent with existing forecasts.
Hong Kong’s Hang Seng Index gained 0.48%.
China’s Shanghai Composite was 0.43% higher while the Shenzhen Component edged down 0.03%. Authorities are urging large private and state-owned property companies to acquire real estate projects from troubled developers, in order to reduce the risks posed to the economy by the latter’s mounting debt.
However, the mood was somewhat brighter in early Asian trading as their U.S. counterpart clawed back some losses. However, volumes were thin as the holidays approach.
U.S. shares had retreated more than 1% after President Joe Biden’s social spending and climate bill was dealt a big blow. Senator Joe Manchin said on Sunday that he will not support Biden’s Build Back Better package, a $1.75 trillion domestic investment bill.
Goldman Sachs Group Inc. economists cut their U.S. growth forecasts after Manchin’s comments, while the S&P 500 recorded its biggest three-day drop since September 2021.
There’s kind of two dynamics going on. Probably the most important one is the imminent reduction in liquidity. On top of that, you have the omicron concern, Infrastructure Capital Management chief executive officer Jay Hatfield told Bloomberg.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.